Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

RFP – Research, Monitoring and Outcomes for Vaccine Safety

by Global Biodefense Staff
January 14, 2015
Dual Purpose Vaccine for Ebola and Rabies

The National Vaccine Program Office (NVPO) has launched a pilot cooperative agreement grant program to partner with organizations to conduct research that will strengthen the current U.S. vaccine safety enterprise.

The program’s objective is to conduct research in safety profile of new vaccines during the early development stage, developing or modifying existing vaccines to improve their safety, and conducting applied research that will have a direct impact on the current vaccine safety monitoring system.

NVPO is particularly interested in projects related to researching, establishing or testing the vaccine safety profile of vaccines that are currently recommended for or are expected to be routinely administered to pregnant women and/or newborns.

This pilot program encourages collaborative efforts with experts across fields to maximize the results and impact of the research project. NVPO scientific staff will have substantial programmatic involvement, providing guidance and support in the design and development of research projects.

The NVPO states it intends to select and award two cooperative agreements of $250,000 each via this opportunity.

Further details are available via announcement NV-VSR-15-001. Current Closing Date for Applications: April 15, 2015.

Tags: AwardsInfluenzaVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC